Biotech pauses trial after second patient death linked to gene therapy ...Middle East

Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biotech pauses trial after second patient death linked to gene therapy )

Also on site :

• Blitzy Partners with Galatea Associates to Deliver AI-Native Development for Financial Services
• Companies Warn SEC That Mass Deportations Pose Serious Business Risk
• OPEC Oil Output Increase Falls Short of Target